DIVISLAB / Q2-FY26 / promises

Measure what management said.

Divi's Laboratories · A quarter-by-quarter view of forward statements and whether delivery is visible yet.

Research layer active

ConCallIQ research layer

Signal, with the source still visible.

Use the controls below to narrow the view, then follow the evidence into the next layer of context.

PositiveQ2-FY26 · 2025-10-30Back to quarter ↗

Management delivery ledger

Promises over time.

3 tracked

Q3-FY26 · Q2 FY26

Capex for FY26 to exceed ₹2,000 crore

Current-quarter commentary contains related risk or weakness, so the promise appears not to have been delivered yet.

missed

heuristic_v1

Q3-FY26 · Q2 FY26

Constant currency revenue growth ~10-11% for FY26

Current-quarter commentary contains related risk or weakness, so the promise appears not to have been delivered yet.

missed

heuristic_v1

Q3-FY26 · Q2 FY26

Generic pricing pressure to persist for next 2 quarters

Current-quarter commentary contains related risk or weakness, so the promise appears not to have been delivered yet.

missed

heuristic_v1